Boulbou Mary S, Gourgoulianis Konstantinos I, Petinaki Efthymia A, Klisiaris Vasilios K, Maniatis Antonios N, Molyvdas Paschalis A
Department of Respiratory Medicine, University Hospital of Larissa, Larissa, Greece.
Can Respir J. 2003 Jul-Aug;10(5):259-64. doi: 10.1155/2003/295238.
Lung function in diabetes has been reported in several studies with contradictory results. Diabetes mellitus increases expression of adhesion molecules through hyperglycemia. These molecules play an important role in the pathophysiological dysfunction of the vasculature.
To explore the possible relationship between lung function and circulating levels of adhesion molecules in diabetes.
Sixteen type 1 diabetic patients, 33 type 2 diabetic patients and 22 healthy subjects matched for age and sex were studied. Spirometry measurements were performed and pulmonary diffusion capacity for carbon monoxide (DLco) was measured in sitting and supine positions by the single-breath method corrected by alveolar volume (VA). Glycosylated hemoglobin, retinopathy and nephropathy were included as parameters of metabolic control and diabetic complications. Circulating levels of soluble E-selectin and vascular cell adhesion molecule-1 (VCAM-1) were determined in all subjects.
Diabetic subjects showed lower variation in DLco and DLco/VA by changing posture from sitting to supine position (P=0.043 and P<0.001, respectively), and showed reduced total lung capacity (P<0.001) and forced expiratory volume in 1 s/forced vital capacity (P=0.009) compared with healthy control subjects. Serum concentrations of E-selectin were elevated in diabetic patients (P<0.001). There was no difference in serum VCAM-1 concentrations between diabetic and control subjects. On stepwise regression analysis, E-selectin concentrations were the most important contributing factor to the variation in DLco/VA.
Diabetic patients show lower pulmonary volumes and variation in DLco by changing posture from sitting to supine position, and they also show increased levels of E-selectin. A possible explanation is impaired pulmonary microvasculature, because adhesion molecules seem to be sensitive markers of endothelial activation and damage seen in diabetes.
多项研究报告了糖尿病患者的肺功能,结果相互矛盾。糖尿病通过高血糖增加黏附分子的表达。这些分子在血管系统的病理生理功能障碍中起重要作用。
探讨糖尿病患者肺功能与循环中黏附分子水平之间的可能关系。
对16例1型糖尿病患者、33例2型糖尿病患者以及22名年龄和性别相匹配的健康受试者进行研究。进行肺量计测量,并采用经肺泡容积(VA)校正的单次呼吸法测量坐位和仰卧位的一氧化碳肺弥散量(DLco)。糖化血红蛋白、视网膜病变和肾病作为代谢控制和糖尿病并发症的参数。测定所有受试者循环中可溶性E-选择素和血管细胞黏附分子-1(VCAM-1)的水平。
与健康对照受试者相比,糖尿病受试者从坐位变为仰卧位时DLco和DLco/VA的变化较小(分别为P = 0.043和P < 0.001),且总肺容量降低(P < 0.001),1秒用力呼气量/用力肺活量降低(P = 0.009)。糖尿病患者血清E-选择素浓度升高(P < 0.001)。糖尿病患者和对照受试者血清VCAM-1浓度无差异。逐步回归分析显示,E-选择素浓度是DLco/VA变化的最重要影响因素。
糖尿病患者从坐位变为仰卧位时肺容积降低,DLco变化较小,且E-选择素水平升高。一种可能的解释是肺微血管受损,因为黏附分子似乎是糖尿病中内皮激活和损伤的敏感标志物。